FIGURE 3.

GMLVQ* analysis, including steroid values, BMI and age, has excellent potential utility as a screening tool to identify individuals with advanced NAFLD fibrosis within the general population. There was excellent separation between controls and those with advanced NAFLD fibrosis (A) with the corresponding ROC AUC analysis (B). The performance of GMLVQ* to identify patients with NAFLD cirrhosis in the general population (control vs F4) is excellent with perfect separation (C and D). BMI, body mass index; GMLVQ, Generalised Matrix Learning Vector Quantisation; NAFLD, non‐alcoholic fatty liver disease; ROC, receiver operating characteristics